glp 1 and kidney transplant GLP-1 Use After Linked to Nearly 50% Lower Graft Loss-EMJ Effects of GLP-1 receptor agonists

Your clinic or pharmacy can help initiate prior authorization documentation

Flexible Spending Accounts (FSAs) can cover FDA-approved GLP-1 receptor agonists, and PlexusDx compounded medications qualify under this category

Secondary outcomes, including ACR20 responses and minimal disease activity, also favored combination therapy

Heat it

However, this landscape could shift next year with the anticipated approval of: The oral version of Wegovy for obesity treatment (approved just yesterday) Eli Lillys Orforglipron

As of January 2026, more than 70,000 patients were already being treated with Mounjaro in France without reimbursement, illustrating the scale of suppressed demand now set to be released